Hidradenitis
RecruitingEvaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
- Disease:Hidradenitis
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Citryll B.V.
Rare diseases
Investigational molecules
Locations
Rk Gebouw, Kloosterstraat 9, 5349 AB, The Netherlands
Citryll B.V. focuses on inflammatory mediated immune diseases with studies aimed at understanding how its investigational program behaves in immune-driven conditions. This area reflects interest in immunology and the treatment of chronic inflammatory disorders.
The sponsor’s research activity in this area includes work spanning multiple countries and collaborating sites, supporting clinical evaluation in broad immune-inflammatory settings.
Citryll B.V. runs clinical trials in conditions such as Hidradenitis, Autoimmune disorder, Rheumatoid arthritis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
The Netherlands
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.